A detailed history of Tiaa Trust, National Association transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tiaa Trust, National Association holds 5,589 shares of VRTX stock, worth $2.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,589
Previous 5,348 4.51%
Holding current value
$2.54 Million
Previous $2.24 Million 17.18%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$392.81 - $485.53 $94,667 - $117,012
241 Added 4.51%
5,589 $2.62 Million
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $10,599 - $11,598
26 Added 0.49%
5,348 $2.24 Million
Q4 2023

Jan 23, 2024

SELL
$343.0 - $410.68 $6,860 - $8,213
-20 Reduced 0.37%
5,322 $2.17 Million
Q3 2023

Oct 27, 2023

BUY
$338.18 - $362.46 $1.81 Million - $1.94 Million
5,342 New
5,342 $1.86 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $117B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tiaa Trust, National Association Portfolio

Follow Tiaa Trust, National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa Trust, National Association, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa Trust, National Association with notifications on news.